Enzo Biochem, Inc. · New York, NY United States (NYSE: ENZ)
| 527 Madison Ave. | Phone: 212-583-0100 |
| New York, NY | |
| 10022 | |
| United States | 
Map This Company |
Enzo Biochem, Inc. Rankings
| S&P 600 |
More Companies in These Related Industries: Toxicology Laboratories, Analytical Laboratory Instrument MfgCompany Description
For Enzo Biochem, antisense is perfectly sensible. The biotech company's Enzo Therapeutics segment develops antisense technology, a kind of gene therapy that switches off disease-causing genes, to fight such illnesses as HIV and Crohn's disease. Its work is funded by its two other segments: Enzo Clinical Labs which provides diagnostic testing services in the New York City area and Enzo Life Sciences which makes reagents used in research by pharmaceutical and biotech companies, as well as academic institutions. Enzo Biochem has collaborative partnerships with academic and research centers such as the
Enzo Biochem, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NYSE: ENZ Headquarters |
|---|---|
| Fiscal Year-End | July |
| 2011 Employees | 606 |
Executives
21 executives listed for Enzo Biochem, Inc.'s New York, NY location.
| Chairman, CEO, and Secretary | Elazar Rabbani | |
|---|---|---|
| Principal | John Pomponio | |
| President, CFO, Principal Accounting Officer, Treasurer, and Director | Barry Weiner |